Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Mental health

Parkinson's symptom that starts years before hand tremors

Parkinson's is a degenerative, neurological condition with no cure

Liverpool Echo

The FDA approved the first Alzheimer’s drug that may really work. A Penn physician explains why you probably can’t get it, yet

The FDA on Friday authorized the use of the Alzheimer’s drug lecanemab, the first drug clearly shown to slow the progress of the debilitating brain disease.

The Philadelphia Inquirer

New hope for Alzheimer’s sufferers as FDA gives fast-track approval to experimental drug

The study also showed that Leqembi carries a risk of brain swelling and bleeding

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Alzheimer’s drug that slows disease progression approved by FDA

U.S. health officials have approved a new Alzheimer’s drug that modestly slows the brain-robbing disease

The Independent UK

Alzheimer's drug that modestly slows disease OK'd by FDA

U.S. health officials have approved a new Alzheimer’s drug that modestly slows the brain-robbing disease

The Independent UK

Brits putting their health at risk by not taking a simple hearing test, charity says

The Royal National Institute for Deaf People (RNID) says only 6% of people in the UK who have not been diagnosed with hearing loss had a hearing test last year, compared with 46% who took an eye test

Daily Mirror

Commentary: We need to take bold steps to help our struggling youths in 2023

Starting the new year with legislation that prohibits anyone younger than 18 from having a social media account would benefit our youths. In Texas, that could become a reality. A state representative there has proposed legislation that would ban minors from having social media profiles. While it certainly will be…

Chicago Tribune

Read news from The Economist, FT, and more,
with one subscription

Participant taking part in experimental trial for Alzheimer's drug dies suddenly

A 65-year-old has died after taking part in an experimental clinical trial for Alzheimer’s disease, with a new study saying their passing could have been related to the drug

Daily Mirror

Travelling to see family and friends ‘good for health’

Experts found that people who left their local community were more likely to report good health compared to those who stayed closer to home.

The Independent UK

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

The Independent UK

America's loneliness fuels fascism

Both young Americans and seniors feel increasingly isolated — and this problem is central to our political crisis

Salon

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

The Independent UK

Child referrals for mental health care in England up 39% in a year

Pandemic, social inequality, austerity and online harm fuelling soaring NHS referrals, say experts

The Guardian - UK

Medic explains 'feeling sad' in winter may be a genuine medical issue

It is normal to feel down when the weather and seasons change but it may be a sign of Seasonal Affective Disorder

Liverpool Echo

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

Glasgow Live

Glasgow Memory Clinic begin tests on groundbreaking Parkinson's medication

The leading Alzheimer's clinical research centre started the ‘Orchestra’ Study in the summer, designed for people who have very mild symptoms or have recently been diagnosed with Parkinson’s.

Nottingham Post

Nottinghamshire man with Parkinson's can 'hold wife's hand again' after getting a new eye device

Derrick says wearing the device was "like magic"

The Philadelphia Inquirer

What to know about the new drug trial for Alzheimer's

PHILADELPHIA — A new drug designed to ward off Alzheimer's is being tested at more than 100 sites around the world, including the University of Pennsylvania.

Get all your
news in one place.

100's of premium titles.
One news app.

Miami Herald

Why do some people get Alzheimer’s and others don’t? How a new tool checks your risk

Why do some people develop Alzheimer’s disease and others don’t? What makes one person’s brain healthier than another’s? And what can be done to improve, or at least slow, a brain’s deterioration?

The National (Scotland)

Emma Roddick: ‘People think I shouldn’t be an MSP with my mental health issues’

IT’s all very well politicians, celebrities and world leaders raising awareness of anxiety and depression and encouraging people to talk on World…

Dynamite News

New Biomarker Test Can Identify Alzheimer's Neurodegeneration In Blood: Study

A team of neuroscientists led by a University of Pittsburgh School of Medicine researcher developed a blood test to detect a new marker of Alzheimer's disease neurodegeneration. Read on for details:

Daily Record

Woman battles depression by doing something new every day for a year

Jess Mell, 34, has struggled with depression but says she is the happiest she has been in a decade after trying new things for 365 days.

The Independent UK

New blood test developed to detect signs of Alzheimer’s disease

‘A blood test is cheaper, safer and easier to administer, and it can improve clinical confidence in diagnosing Alzheimer’s’

The Independent UK

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

Dynamite News

Traumatic Brain Injury, PTSD Associated With Alzheimer's: Research

The medical profession has never before investigated the effects of traumatic brain injury (TBI), post-traumatic stress disorder (PTSD) and genetic risk factors in a sizable cohort. Read on for details:

1 … 142 143 144 145

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Pennsylvania

121 stories

Eisai

81 stories

US Food and Drug Administration

63 stories

RNID

33 stories

Alzheimer Association

19 stories

DBI

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.